Basic Information
Under the leadership of co-founder and CEO Dr. Umar Naeem Ahmad, Abtrace uses machine learning to provide advanced digital solutions that enable healthcare professionals to respond to and manage patients' current illnesses while identifying the first clinical signs of new diseases. The company has developed an artificial intelligence tool that can be integrated into electronic health record (EHR) databases to identify tests or treatments that patients with long-term health conditions may need or benefit from. The software allows general practitioners and healthcare assistants (HCAs) to make more informed decisions, automates key elements of disease monitoring, and ensures patients receive consistent and effective care. The system recommends actions based on an individual's medical history and insights learned from broader data points, facilitating proactive early intervention and uncovering trends that might otherwise be overlooked.
Abtrace Ltd
London,England,United Kingdom
less than 15 people
August 24, 2018
team@abtrace.co

